January 13, 2012 — The US Food and Drug Administration (FDA) yesterday issued an updated guidance on voluntary product recalls involving Bedford Laboratories injection drugs that were initially made ...
Vecuronium bromide 10mg/10mL; pwd for IV inj after reconstitution; contains benzyl alcohol, mannitol. <7wks: not recommended. Individualize. >7wks–10yrs: see literature. ≥10yrs: Relaxation for ...
Vecuronium Bromide for Injection, a non-depolarizing neuromuscular blocker, is indicated as an adjunct to general anesthesia. Teva announced the reintroduction and availability of Vecuronium Bromide ...
SCHAUMBURG, Ill., Aug. 18, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced the launch of vecuronium bromide for injection, a neuromuscular blocking agent, in 10 and ...
Sagent Pharmaceuticals Inc has expanded a nationwide recall of vecuronium bromide for injection 10 mg, the US Food and Drug Administration (FDA) said today. Vecuronium bromide for injection is a ...
BEDFORD, Ohio, Jan. 10, 2012 /PRNewswire/ -- Bedford Laboratories™ today issued updated guidance on the following nationwide voluntary product recalls originally issued on August 2, 2011: Lot 1942980 ...
Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (lyophilized ...
The FDA approved Bridion injections to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide. 1. Rocuronium bromide and vecuronium bromide are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback